Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:44 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 30,734,957 11.600% | -2,792,205 (-8.33%) | Filing History |
| 2024-02-22 4:06 pm Purchase | 2024-02-20 | 13D | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 65,872,764 100.000% | 28,010,632 (+73.98%) | Filing History |
| 2024-02-13 6:41 pm Unchanged | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 14.400% | 0 (Unchanged) | Filing History |
| 2024-02-13 6:40 pm Unchanged | 2023-12-31 | 13G | Achilles Therapeutics plc ACHL | Syncona Portfolio Ltd | 11,086,909 27.200% | 0 (Unchanged) | Filing History |
| 2023-11-24 07:30 am Unchanged | 2023-11-22 | 13D | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 37,862,132 57.900% | 0 (Unchanged) | Filing History |
| 2023-10-18 06:04 am Purchase | 2023-10-17 | 13D | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 37,862,132 57.920% | 37,862,132 (New Position) | Filing History |
| 2023-02-14 10:28 am Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 19.700% | 14,000,000 (+71.70%) | Filing History |
| 2022-03-25 4:07 pm Purchase | 2022-03-15 | 13D | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 2,524,143 62.270% | 1,269,841 (+101.24%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2021-12-31 | 13G | Achilles Therapeutics plc ACHL | Syncona Portfolio Ltd | 11,086,909 27.300% | 11,086,909 (New Position) | Filing History |
| 2022-02-11 12:21 pm Purchase | 2021-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 19,527,162 26.800% | 3,571,428 (+22.38%) | Filing History |
| 2022-02-11 12:20 pm Unchanged | 2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 1,254,302 52.500% | 0 (Unchanged) | Filing History |
| 2021-02-12 11:04 am Purchase | 2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Syncona Portfolio Ltd | 1,254,302 54.200% | 1,254,302 (New Position) | Filing History |
| 2021-02-12 10:43 am Purchase | 2020-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 15,955,734 30.500% | 1,363,636 (+9.35%) | Filing History |
| 2020-02-11 4:30 pm Purchase | 2019-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 14,592,098 32.400% | 1,000,000 (+7.36%) | Filing History |